InvestorsObserver
×
News Home

Should You Buy Merck & Co., Inc. (MRK) in Drug Manufacturers - General Industry?

Wednesday, August 10, 2022 06:30 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Merck & Co., Inc. (MRK) in Drug Manufacturers - General Industry?

Merck & Co., Inc. (MRK) is the highest overall rated company in the Drug Manufacturers - General industry with an overall score of 83. MRK is up 19.06% so far this year after the company closed yesterday at $89.52. The overall score measures the company's performance based-off both short and long term indicators and means that MRK scores better than 83% of the overall market.

Overall Score - 83
MRK has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on MRK!
Merck & Co., Inc. is a strong performer in the Drug Manufacturers - General industry, which has an average overall score of 52. This means that, on average, the stocks in this industry score higher than 52% of the stock market.
To see InvestorsObserver's Sentiment Score for Merck & Co., Inc. click here. MRK has been trading bullishly recently. The stock is trading up 2.18% this week following yesterday's decline. MRK has an average analyst ranking of Strong Buy with an average price target of $98.312. Click Here to get the full Stock Report for Merck & Co., Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App